AHA Scientific Sessions 2023

It's been 100 years since the American Heart Association (AHA) began supporting and focusing on the advancement of cardiovascular science. The AHA was founded in the year 1924 by six cardiologists, and today it has more than a thousand members who have dedicated their knowledge to better heart health. AHA 2023 marks the 76th anniversary of AHA and takes place both virtually and in-person at the Pennsylvania Convention Center in Philadelphia, PA.

These sessions are aimed at improving cardiovascular health and science. Some of the topics covered throughout the event include:

• Championing scientific discovery and clinical practice
• Heart failure guidelines
• Strategies to promote equitable healthcare
• Profiles in cardiovascular diseases
• Imaging of structural heart interventions

Presenters and Topics

Shady Abohashem, MD

• Measurements Predict Progression of Aortic Valve Calcification in Humans
• Higher Genetic Risk for Neuroticism Heightens Cardiovascular Risk Related to Chronic Sleep Deprivation

Abdulaziz Al-Hamam, MD

Physical Activity Associates With a Greater Reduction in Heart Failure Risk Among Individuals With Depression and/or Anxiety

Safia Chatur, MD

Sacubitril/Valsartan in Patients With Heart Failure and Deterioration of Kidney Function to Estimated Glomerular Filtration Rate Less Than 30ml/min/1.73m2: Insights From PARAGON-HF and PARADIGM-HF

Giovanni Civieri, MD, & Ahmed Tawakol, MD

Depression and Anxiety Accelerate the Rate of Gain of Cardiovascular Risk Factors: Mechanism Leading to Increased Risk of Cardiac Events

David M. Dudzinski, MD, JD

Critical Care Cardiology With a Novel, Rapid-fire Case Based Session for Critical Care Cardiology Will Feature Experts for Panel Discussions

Michael Honigberg, MD, MPP

Clonal Hematopoiesis of Indeterminate Potential Predicts Incident Cardiac Arrhythmias

Min Seo Kim, MD

Body Mass Index Threshold for Obesity Should Be Personalized Based on Polygenic Score

Emily Lau, MD, MPH

• HFpEF in Women: A Different Disease?
• Sex Differences in Protein Biomarkers and Measures of Fat Distribution
• Natural Language Processing for Adjudication for Heart Failure Hospitalizations in a Multi-center Clinical Trial
• Electrocardiogram-based Artificial Intelligence Predicts Incident Heart Failure
• Leveraging Deep Learning to Elucidate Subclinical Aortic Stenosis Risk
• Deep Learning-based GWAS of Aortic Valve Function Links 81 Loci to Aortic Stenosis Risk
• Association of Eicosanoid Metabolites With Cardiac Structure and Function

Michael T. Lu, MD, MPH

Future of Lipid Lowering Therapy - Novel Mechanisms and Approaches

Pradeep Natarajan, MD, MMSc

Joseph A. Vita Award

Ahmed Tawakol, MD

Physical Activity Associates With a Greater Reduction in Heart Failure Risk Among Individuals With Depression and/or Anxiety

Sarah Urbut, MD, PhD

MSGene: Derivation and Validation of a Multistate Model for Lifetime Risk of Coronary Artery Disease Using Genetic Risk and the Electronic Health Record

Jason Wasfy, MD

• Balance MD and NP Care
• How to Improve Quality Infrastructure for Cardiology Care

Meagan Wasfy, MD

• Running Interference: To Screen or Not to Screen
• Apples to Apples: Cardiopulmonary Exercise Testing Findings in Healthy Athletes versus Equally Fit Patients With Hypertrophic Cardiomyopathy

Doreen Yeh, MD

Cardio-Obstetrics and HF: Clinical Pearls and Management Pointers